全幻灯片影像市场报告：2031 年趋势、预测与竞争分析

由于远端病理学、细胞病理学、免疫组织化学和血液病理学市场的机会，全球全幻灯片成像 (WSI) 市场的未来前景光明。预计 2025 年至 2031 年期间，全球全幻灯片成像市场将以 6.5% 的复合年增长率成长。该市场的主要驱动力是数位病理解决方案的采用率不断提高、药物发现研究活动的扩大以及对高效准确诊断的需求不断增加。

• Lucintel 预测，在预测期内，扫描器将成为所有技术中成长最快的技术。
• 根据应用，远端病理学预计将在预测期内实现最高成长。
• 根据地区，预计北美将在预测期内实现最高成长。

整个幻灯片成像市场的策略性成长机会

整个幻灯片成像市场提供了众多策略性成长机会，可以显着改善诊断业务和患者治疗结果。随着技术的不断进步和医疗保健需求的不断发展，相关人员可以利用这些机会扩大其影响力并改善其服务。识别这些成长领域并采取行动可以在快速变化的环境中提供可持续的竞争优势。

• 扩大远端病理学服务：日益增长的远端病理学需求为全切片成像提供者提供了一个机会，可以加强他们的远距离诊断能力，特别是在服务不足的地区，促进专家咨询，并机会获得优质护理的机会。
• 开发人工智慧主导的解决方案：对人工智慧技术的投资将促进更先进的全切片成像平台的开发，从而增强影像分析、自动化诊断过程并提高准确性，有助于满足对可靠诊断工具日益增长的需求。
• 与教育机构的合作：与大学和研究中心合作制定培训计划和研究倡议将有助于建立一支熟悉全幻灯片成像技术的熟练劳动力队伍，提高其采用率，并确保其在临床实践中有效应用。
• 优先考虑与电子健康记录(EHR) 的整合：提高整个幻灯片成像系统和 EHR互通性可以简化工作流程、改善数据共用，并为病理学家提供对患者病历的便捷访问，以改善整体诊断过程。
• 发展新兴市场：拓展新兴市场代表着巨大的成长机会。随着这些地区医疗保健基础设施的发展，对可以透自订全幻灯片成像解决的数位病理学解决方案的需求日益增长。

整个幻灯片成像市场充满了推动创新和改善医疗保健服务的策略性成长机会。透过利用这些机会，相关人员可以为成功做好准备，并为数位病理学的发展做出有意义的贡献。

全幻灯片成像市场驱动因素与挑战

整个幻灯片成像市场充满了推动创新和改善医疗保健服务的策略性成长机会。透过利用这些机会，相关人员可以为成功做好准备，并为数位病理学的发展做出有意义的贡献。

推动整个投影片影像市场发展的因素有：

• 对数位病理学的需求不断增加：随着医疗保健提供者寻求改善患者治疗结果并简化工作流程，对高效、准确的诊断工具的需求不断增长，推动了 WSI 的采用。
• 技术进步：影像处理技术的不断进步，例如更高的解析度和更好的分析软体，正在提高 WSI 系统的功能，并使其对寻求有效解决方案的医疗机构具有吸引力。
• 监管部门的核准和支持：FDA（美国食品药物管理局）等监管机构对 WSI 技术的核准不断增加，这增加了医疗保健专业人士的信心，并鼓励对数位病理学的投资，从而加速了市场成长。
• 整合人工智慧：人工智慧与 WSI 系统的整合正在彻底改变诊断方式，实现更快、更准确的影像分析，使病理学家能够做出更明智的决策，并改善整体患者照护。
• 远端医疗的普及率不断提高：远端医疗的普及率不断提高，尤其是在疫情远端医疗，这推动了对远距病理学解决方案的需求，使 WSI 成为远距咨询和改善专科护理服务的重要工具。

整个幻灯片影像市场面临的挑战如下：

• 前期成本高：采用 WSI 系统的高成本可能会成为许多医疗机构广泛采用该系统的重大障碍，尤其是预算有限的小型医疗机构。
• 资料隐私问题：由于 WSI 依赖敏感患者资讯的数位储存和共用，资料隐私和安全问题可能是一个挑战，需要采取严格的措施来保护患者的隐私。
• 与现有系统的整合：将 WSI 技术与现有实验室和医院资讯系统整合可能很复杂，需要额外的培训和资源才能确保无缝运​​作。

整个幻灯片成像市场具有强劲的成长动力和挑战。应对这些挑战并利用驱动因素将使相关人员能够优化他们的策略并有助于成功采用数位病理解决方案。

目录

第一章执行摘要

第二章全球全幻灯片成像市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球全幻灯片成像市场趋势（2019-2024 年）和预测（2025-2031 年）
• 全球全幻灯片成像市场（按技术）
  • 扫描器
  • IT基础设施
  • 检视器
  • 影像管理系统
• 全球全幻灯片成像市场（按应用）
  • 远距病理学（远端病理诊断）
  • 细胞病理学
  • 免疫组织化学
  • 血液病理学
  • 其他的
• 全球全幻灯片成像市场（按最终用途划分）
  • 学术机构
  • 研究
  • 其他的

第四章区域市场趋势与预测分析（2019-2031）

• 全球全幻灯片成像市场（按地区）
• 北美全幻灯片成像市场
• 欧洲全幻灯片成像市场
• 亚太全幻灯片成像市场
• 世界其他地区整体幻灯片成像市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球全幻灯片成像市场成长机会（按技术）
  • 全球全幻灯片成像市场的成长机会（按应用）
  • 全球全幻灯片成像市场成长机会（按最终用途划分）
  • 全球全幻灯片成像市场各区域成长机会
• 全球全幻灯片成像市场的新趋势
• 战略分析
  • 新产品开发
  • 全球全幻灯片成像市场的产能扩张
  • 全球全幻灯片成像市场的企业合併
  • 认证和许可

第七章主要企业简介

• Olympus Corporation
• Koninklijke Philips
• Leica Microsystems
• Nikon Corporation
• Visiopharm
• 3Dhistech
• Hamamatsu Photonics KK
• Indica Labs
• Mikroscan Technologies
• Akoya Biosciences

The future of the global whole slide imaging market looks promising with opportunities in the telepathology, cytopathology, immunohistochemistry, and hematopathology markets. The global whole slide imaging market is expected to grow with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing adoption of digital pathology solutions, expanding research activities of drug discovery, and the rising need for efficient and accurate diagnosis.

• Lucintel forecasts that, within the technology category, scanner is expected to witness the highest growth over the forecast period.
• Within the application category, telepathology is expected to witness the highest growth over the forecast period.
• In terms of regions, North America is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Whole Slide Imaging Market

The whole slide imaging market is evolving rapidly, influenced by technological advancements and changing healthcare needs. As the demand for efficient and accurate diagnostic solutions grows, several trends are shaping the future of whole slide imaging. These trends reflect the integration of artificial intelligence, improved workflow efficiencies, and increased accessibility of digital pathology.

• Integration of Artificial Intelligence: The incorporation of AI algorithms in whole slide imaging is enhancing diagnostic accuracy and speed, enabling pathologists to identify abnormalities more effectively and reducing the potential for human error.
• Cloud-Based Solutions: The shift toward cloud-based storage and analysis is allowing greater data accessibility and collaboration among healthcare professionals, making it easier to share and review slides remotely, thus streamlining workflows.
• Telepathology Adoption: The rise of telepathology is transforming how pathology services are delivered, particularly in remote or underserved areas, facilitating consultations and second opinions through digital slide sharing, which enhances patient care.
• Regulatory Support: Increasing regulatory approvals for whole slide imaging technologies by bodies like the FDA are driving market growth. These approvals foster confidence in digital pathology solutions and encourage healthcare institutions to adopt these innovations.
• Educational Initiatives: Growing emphasis on educational programs and training for pathologists on whole slide imaging technology is crucial. As professionals become more familiar with digital tools, the adoption rate is expected to rise, promoting better diagnostic practices.

The whole slide imaging market is poised for significant advancements driven by these emerging trends. As technology continues to evolve, stakeholders in healthcare are likely to see enhanced diagnostic capabilities and improved patient outcomes, marking a new era in pathology.

Recent Developments in the Whole Slide Imaging Market

The whole slide imaging market is experiencing rapid advancements, driven by technological innovations, regulatory changes, and increased adoption in clinical settings. These developments are reshaping the landscape of digital pathology, making diagnostic processes more efficient and accurate. As healthcare continues to evolve, key milestones highlight the potential of whole slide imaging to transform pathology practices and improve patient care.

• Increased AI Integration: Recent advancements in artificial intelligence are enhancing whole slide imaging applications, with algorithms now capable of analyzing slides for complex patterns, thereby supporting pathologists in diagnostics and improving accuracy and speed.
• Expansion of Regulatory Approvals: Regulatory bodies, such as the FDA, are increasingly approving whole slide imaging systems for clinical use. These approvals not only validate the technology's reliability but also encourage healthcare facilities to invest in digital pathology solutions.
• Advancements in Image Analysis Software: The development of sophisticated image analysis software is enabling more detailed examination of whole slide images, allowing pathologists to extract valuable insights and supporting more informed clinical decisions based on enhanced visualization.
• Growth of Remote Pathology Services: The demand for remote pathology services is on the rise, particularly following the pandemic. Whole slide imaging technology is facilitating telepathology, enabling specialists to provide consultations and diagnostics from distant locations efficiently.
• Increased Investment in Research: Significant investments in research and development by both public and private sectors are driving innovation in whole slide imaging technologies. These funds are aimed at enhancing functionality, improving interoperability, and advancing education in digital pathology.

Recent developments in the whole slide imaging market reflect a dynamic evolution in the field of pathology. With ongoing innovations and growing acceptance among healthcare professionals, whole slide imaging is set to play a pivotal role in transforming diagnostic practices and enhancing patient outcomes in the coming years.

Strategic Growth Opportunities for Whole Slide Imaging Market

The whole slide imaging market presents numerous strategic growth opportunities that can significantly enhance diagnostic practices and patient outcomes. As technology continues to advance and healthcare needs evolve, stakeholders can leverage these opportunities to expand their reach and improve services. Identifying and acting on these growth areas can lead to sustained competitive advantages in a rapidly changing landscape.

• Expanding Telepathology Services: The growing need for telepathology offers an opportunity for whole slide imaging providers to enhance remote diagnostic capabilities, particularly in underserved regions, facilitating expert consultations and improving access to quality healthcare.
• Development of AI-Driven Solutions: Investing in AI technologies can enable companies to create more advanced whole slide imaging platforms that enhance image analysis, automate diagnostic processes, and improve accuracy, thereby meeting the increasing demand for reliable diagnostic tools.
• Collaboration with Educational Institutions: Partnering with universities and research centers to develop training programs and research initiatives can foster a skilled workforce familiar with whole slide imaging technology, promoting its adoption and ensuring effective utilization in clinical practice.
• Focus on Integration with Electronic Health Records (EHR): Enhancing interoperability between whole slide imaging systems and EHRs can streamline workflows, improve data sharing, and ensure that pathologists have immediate access to patient histories, thereby enhancing the overall diagnostic process.
• Exploring Emerging Markets: Expanding operations into emerging markets presents a significant growth opportunity. As healthcare infrastructure develops in these regions, there is a rising demand for digital pathology solutions, which can be met with tailored whole slide imaging offerings.

The whole slide imaging market is ripe with strategic growth opportunities that can drive innovation and improve healthcare delivery. By capitalizing on these avenues, stakeholders can position themselves for success and make meaningful contributions to the evolution of digital pathology.

Whole Slide Imaging Market Driver and Challenges

The whole slide imaging market is ripe with strategic growth opportunities that can drive innovation and improve healthcare delivery. By capitalizing on these avenues, stakeholders can position themselves for success and make meaningful contributions to the evolution of digital pathology.

The factors responsible for driving the whole slide imaging market include:

• Increasing Demand for Digital Pathology: The rising need for efficient and accurate diagnostic tools is driving the adoption of WSI, as healthcare providers seek to improve patient outcomes and streamline workflow processes.
• Advancements in Technology: Continuous advancements in imaging technology, including higher resolution and better analysis software, are enhancing the capabilities of WSI systems, making them more appealing to medical institutions looking for effective solutions.
• Regulatory Approvals and Support: Growing regulatory approvals for WSI technologies from agencies like the FDA are fostering trust and encouraging healthcare providers to invest in digital pathology, thereby accelerating market growth.
• Integration of Artificial Intelligence: The integration of AI into WSI systems is revolutionizing diagnostics by enabling faster and more accurate image analysis, helping pathologists make informed decisions, and improving overall patient care.
• Expanding Telemedicine Adoption: The increased acceptance of telemedicine, particularly post-pandemic, is driving demand for telepathology solutions, making WSI an essential tool for remote consultations and enhancing access to expert care.

Challenges in the whole slide imaging market are:

• High Initial Costs: The high costs associated with implementing WSI systems can be a significant barrier for many healthcare facilities, especially smaller institutions with limited budgets, which may hinder widespread adoption.
• Data Privacy Concerns: As WSI relies on digital storage and sharing of sensitive patient information, concerns about data privacy and security can pose challenges, requiring stringent measures to protect patient confidentiality.
• Integration with Existing Systems: The complexity of integrating WSI technology with existing laboratory and hospital information systems can create operational hurdles, necessitating additional training and resources to ensure seamless functionality.

The whole slide imaging market is characterized by strong growth drivers and notable challenges. By addressing these challenges while capitalizing on the drivers, stakeholders can optimize their strategies and contribute to the successful implementation of digital pathology solutions.

List of Whole Slide Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies whole slide imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the whole slide imaging companies profiled in this report include-

• Olympus Corporation
• Koninklijke Philips
• Leica Microsystems
• Nikon Corporation
• Visiopharm
• 3Dhistech
• Hamamatsu Photonics KK
• Indica Labs
• Mikroscan Technologies
• Akoya Biosciences

Whole Slide Imaging by Segment

The study includes a forecast for the global whole slide imaging market by technology, application, end use, and region.

Whole Slide Imaging Market by Technology [Analysis by Value from 2019 to 2031]:

• Scanners
• IT Infrastructure
• Viewer
• Image Management System

Whole Slide Imaging Market by Application [Analysis by Value from 2019 to 2031]:

• Telepathology
• Cytopathology
• Immunohistochemistry
• Hematopathology
• Others

Whole Slide Imaging Market by End Use [Analysis by Value from 2019 to 2031]:

• Academic Institute
• Research
• Others

Whole Slide Imaging Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Whole Slide Imaging Market

The whole slide imaging market has witnessed significant growth recently, driven by advancements in digital pathology, increasing adoption of telepathology, and rising demand for efficient diagnostic tools. This technology enhances the accuracy of pathology assessments, facilitates remote consultations, and supports educational initiatives. As the market evolves, key players are expanding their offerings and exploring innovative solutions. This report highlights recent developments in the whole slide imaging market across the United States, China, Germany, India, and Japan.

• United States: The U.S. market is rapidly expanding due to increased investments in healthcare technology and regulatory approvals, with companies focusing on enhancing AI integration to improve diagnostic accuracy and workflow efficiency.
• China: The Chinese whole slide imaging market is experiencing robust growth, fueled by government initiatives to modernize healthcare, coupled with rising demand for digital solutions among hospitals and laboratories, as well as significant investments in research and development.
• Germany: Germany is at the forefront of whole slide imaging technology in Europe, driven by strong research institutions and healthcare partnerships. Ongoing regulatory support and funding for innovative solutions are further propelling the market's expansion.
• India: The Indian whole slide imaging market is gaining momentum as healthcare facilities adopt digital pathology solutions. Increasing awareness of the benefits of whole slide imaging among pathologists and educational institutions is encouraging growth in this sector.
• Japan: Japan is leveraging its advanced technology landscape to enhance whole slide imaging applications. The government's focus on digital transformation in healthcare is fostering collaborations between tech companies and medical institutions to improve diagnostic processes.

Features of the Global Whole Slide Imaging Market

Market Size Estimates: Whole slide imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Whole slide imaging market size by technology, application, end use, and region in terms of value ($B).

Regional Analysis: Whole slide imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, applications, end uses, and regions for the whole slide imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the whole slide imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the whole slide imaging market by technology (scanners, IT infrastructure, viewer, and image management system), application (telepathology, cytopathology, immunohistochemistry, hematopathology, and others), end use (academic institute, research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Whole Slide Imaging Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Whole Slide Imaging Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Whole Slide Imaging Market by Technology
  • 3.3.1: Scanners
  • 3.3.2: IT Infrastructure
  • 3.3.3: Viewer
  • 3.3.4: Image Management System
• 3.4: Global Whole Slide Imaging Market by Application
  • 3.4.1: Telepathology
  • 3.4.2: Cytopathology
  • 3.4.3: Immunohistochemistry
  • 3.4.4: Hematopathology
  • 3.4.5: Others
• 3.5: Global Whole Slide Imaging Market by End Use
  • 3.5.1: Academic Institute
  • 3.5.2: Research
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Whole Slide Imaging Market by Region
• 4.2: North American Whole Slide Imaging Market
  • 4.2.1: North American Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.2.2: North American Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
• 4.3: European Whole Slide Imaging Market
  • 4.3.1: European Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.3.2: European Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
• 4.4: APAC Whole Slide Imaging Market
  • 4.4.1: APAC Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.4.2: APAC Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others
• 4.5: ROW Whole Slide Imaging Market
  • 4.5.1: ROW Market by Technology: Scanners, IT Infrastructure, Viewer, and Image Management System
  • 4.5.2: ROW Market by Application: Telepathology, Cytopathology, Immunohistochemistry, Hematopathology, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Whole Slide Imaging Market by Technology
  • 6.1.2: Growth Opportunities for the Global Whole Slide Imaging Market by Application
  • 6.1.3: Growth Opportunities for the Global Whole Slide Imaging Market by End Use
  • 6.1.4: Growth Opportunities for the Global Whole Slide Imaging Market by Region
• 6.2: Emerging Trends in the Global Whole Slide Imaging Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Whole Slide Imaging Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Whole Slide Imaging Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Olympus Corporation
• 7.2: Koninklijke Philips
• 7.3: Leica Microsystems
• 7.4: Nikon Corporation
• 7.5: Visiopharm
• 7.6: 3Dhistech
• 7.7: Hamamatsu Photonics KK
• 7.8: Indica Labs
• 7.9: Mikroscan Technologies
• 7.10: Akoya Biosciences